Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

14
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

15
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
15

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative prognostic value of GNRI, PNI, and CONUT scores for long-term mortality in patients undergoing transcatheter aortic valve replacement.

BMC cardiovascular disorders·2026
Same author

Impact of Reverse Dipper and Non-Dipper Blood Pressure Patterns on Myocardial Performance Index in Hypertensive Patients.

Echocardiography (Mount Kisco, N.Y.)·2026
Same author

The Effect of Renal Artery Stent Implantation on Clinical Outcomes in Patients with Early-Stage (Non-Atrophic Kidney) and Clinically Overt Severe Atherosclerotic Renal Artery Stenosis (ARAS-TR).

Journal of clinical medicine·2026
Same author

Efficacy and safety of combination therapy with statin and ezetimibe in patients failing to achieve target LDL levels at cardiology outpatient clinics in Turkey (COM-TR-OLDL): a real-world observational study.

Lipids in health and disease·2026
Same author

Evaluation of aortic stiffness with an oscillometric arteriograph device in patients with hypertension and ascending aortic aneurysm.

Revista da Associacao Medica Brasileira (1992)·2026
Same author

Impact of 5- and 6-Fr Sheaths on Hemostasis Duration and Access Site Complications in Distal Transradial Approach.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025

相关实验视频

Updated: Jul 14, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.2K

阻塞性 - 非阻塞性过高心肌病:差异和预测因素

Onur Akhan1, Mehmet Kis2, Tuncay Guzel3

  • 1Cardiology Department, Bilecik Training and Research Hospital, Bilecik, Turkey.

Acta cardiologica
|October 9, 2023
PubMed
概括

过高心肌病 (HCM) 可以是阻塞性或非阻塞性. ST段抑郁,QT延长和缩前部运动 (SAM) 是HCM患者阻塞的关键预测因素.

关键词:
左心室过度缩小左心室过度缩小心肌病性心脏病 - 心肌病性心脏病心血管成像 - 心血管成像超声心电图 (Echocardiography) 是一种心声回声仪.

更多相关视频

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.8K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.1K

相关实验视频

Last Updated: Jul 14, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.2K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.8K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.1K

科学领域:

  • 心脏病学 心脏病学
  • 遗传学 遗传学 是一个
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 增高性心肌病变 (HCM) 是一种普遍存在的遗传性心脏病,影响1/500个人的情况.
  • HCM可能导致不良后果,主要是由于左心室外流通道阻塞.
  • 区分阻塞性 (Obs-HCM) 和非阻塞性 (Nonobs-HCM) 形式对于患者管理至关重要.

研究的目的:

  • 确定阻塞性和非阻塞性HCM之间的差异.
  • 通过心电图 (ECG) 和心声回声图 (ECHO) 评估,确定HCM中阻塞的预测因素.
  • 为了将临床,人口和生化特征与HCM阻塞相关联.

主要方法:

  • 国家"LVH-TR研究"的子组分析,包括60名HCM患者 (23名阻塞性,37名非阻塞性).
  • 排除患有心律失常或导电阻塞的患者.
  • 在阻塞性和非阻塞性HCM组之间,ECG和ECHO发现以及临床和生化数据的比较.

主要成果:

  • 在阻塞性HCM中观察到显著更高的身体表面积 (BSA),ST段抑郁,QT/QTc持续时间,左心室质量指数 (LVMI) 和静脉前运动 (SAM) 率.
  • 在单变量分析中,ST段抑郁,QT持续时间,LVMI和SAM是阻塞的显著预测因素.
  • 多变量和相关性分析确定了ST段抑郁 (rho=0.29),QT延长 (rho=0.34) 和SAM (rho=0.62) 作为阻塞的独立预测因素.

结论:

  • ST段抑郁,QT延长和SAM是超性心肌病障碍的重要预测因素.
  • 这些ECG和ECHO发现为区分和预测HCM阻塞提供了宝贵的见解.
  • 该研究的详细比较将为未来对HCM阻塞的研究提供信息.